Background
Hepatic fibrosis represents a wound-healing response of the liver to repeated injuries. It accompanied most chronic liver diseases caused by hepatitis viruses, alcohol abuse, metabolic or autoimmune diseases and chemical toxicity [
1]. Cirrhosis is the end point of the fibrogenic process, and its complications- including portal hypertension, liver failure, and hepatocellular carcinoma- are the ultimate causes of death in most patients [
2]. If treated properly, hepatic fibrosis can be reversed and its progression to irreversible cirrhosis may be prevented.
Liver fibrosis is characterized by the excessive synthesis and deposition of extracellular matrix (ECM) components, particularly collagens, resulting in derangement of the hepatic architecture by forming fibrous scars, and the subsequent development of nodules of regenerating hepatocytes. The major source of ECM accumulation following chronic liver injury is the transformation of hepatic stellate cells (HSCs) from quiescent vitamin A-storing cells into proliferative and fibrogenic myofibroblast-like phenotype, expressing alpha-smooth muscle actin (α-SMA), and dramatically increase the production of collagens [
1,
2].
Matrix metalloproteinases (MMPs) are a group of zinc-dependent proteolytic enzymes that specifically promote ECM degradation [
3]. Tissue inhibitors of metalloproteinases (TIMPs) are a group of functional peptides blocking ECM degradation by inhibiting MMPs proteolytic activity [
4]. Under physiological conditions, MMPs and TIMPs are in homeostasis and they maintain hepatic ECM’s stability by regulating the formation and degradation. However, upon liver injury, an imbalance between MMPs and TIMPs activities has been developed and contribute to ECM accumulation and liver fibrosis [
5]. Studies have shown that MMPs gene therapy can ameliorate experimental rat liver fibrosis [
6,
7]. Furthermore, studies suggest that antibody and antisense oligonucleotides directed to TIMP-1 attenuate rat liver fibrosis [
4]. Therefore, the interplay between MMPs and TIMPs provides a reference point to develop therapies for patients with ongoing fibrosis.
Collective evidences indicated that liver fibrosis incorporates uncontrolled inflammation as a part of its etiology. Nuclear factor- kappa B (NF-κB) is a transcription factor that serves as important regulators of the inflammatory response in liver fibrosis [
8]. NF-κB consists of p65 and p50 subunits of Rel protein family and is ordinarily retained in the cytoplasm in an inactive form. Activation of NF-κB occurs after exposure of cells to oxidative stress and other physiological and pathological stimuli. Activated NF-κB translocates to the nucleus, where it regulates the expression of target genes involved in HSC activation, releasing of proinflammatory cytokines including tumor necrosis factor-alpha (TNF-α), Interleukin-6 (IL-6), IL-1β, and other inflammatory mediators such as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) which are involved in the process of fibrogenesis [
9]. Some reports have indicated that hepatic injury induced by ischemia-reperfusion, alcohol, or endotoxin can be ameliorated by suppressing NF-κB activation in the liver [
8,
10]. In addition, there is evidence showing that, competitive antagonism of NF-κB can inhibit the inflammatory response and prevent CCl
4-induced hepatic injury and fibrosis [
11]. Therefore, in the last few years, much attention has been focused on inhibiting NF-κB pathway as a target for prevention or treatment of liver fibrosis.
Chemical toxicity and chronic inflammation are tightly associated with the continuous generation of reactive oxygen species (ROS) which cause various types of tissue damage including lipid peroxidation, degradation of proteins, strand breakage of DNA, and formation of 8-hydroxy-2’- deoxyguanosine (8-OHdG) [
12,
13]. Through these molecular derangements, highly concentrated ROS may give rise to parenchymal cell death, replaced by tissue fibrosis [
14]. Furthermore, accumulation of 8-OHdG in DNA eventually brings about cellular mutagenesis and subsequent carcinogenesis. Because the liver is an iron-rich organ which contains 30 % of total body storage iron [
15], it is considered to be one of the most susceptible organs to cellular damage or DNA mutagenesis caused by ROS. Therefore, prevention of oxidative genotoxicity is vital for inhibiting liver fibrosis and protection against hepatocarcinogenesis.
Heme oxygenase-1 (HO-1), an important antioxidant enzyme catalyzing the rate-limiting step in heme degradation, is one of the factors protecting against oxidative stress, inflammation, and metabolic dysregulation [
16]. Recently, it has been reported that HO-1 induction by hemin protects the liver against obesity-induced metabolic dysregulation by reducing hepatic oxidative stress and reducing adipose inflammation [
16]. In addition, up-regulation of HO-1 has been shown to protect liver cells from ischemia/reperfusion injury via antioxidant, anti-inflammatory and antiapoptotic mechanisms [
17‐
19]. Formerly, Tsui et al. [
20] suggested the induction of HO-1 in HSCs as a new approach for the treatment of liver fibrosis. Therefore and according to these findings, we hypothesized that dietary factors that promote HO-1 induction might help to protect liver from carbon tetrachloride (CCl
4)-induced oxidative stress and inflammation.
Fruits of the date palm (
Phoenix dactylifera L.) are very commonly consumed in many parts of the world and are a vital component of the diet and a staple food in the Middle East and in North Africa. Nutritional value of date palm fruit is attributed to its high contents of carbohydrates, salts, minerals, dietary fibers, vitamins, fatty acids, amino acids, and protein [
21]. The date palm fruit possesses many useful properties such as antioxidant and antimutagenic activity [
22‐
29], antibacterial [
30], antifungal [
31] and anti-tumoral [
32]. Moreover, the aqueous and ethanolic extracts of dates, were effective in ameliorating the severity of gastric ulceration [
33], nephrotoxicity [
29] and neurotoxicity [
34] via antioxidant mechanisms. Al-Qarawi et al. [
35] and El-Gazzar et al. [
25] demonstrated a hepatoprotective effect of date palm fruit extract on oxidative damage induced by CCl
4. Moreover, aqueous extract of date fruit has a protective effect against thioacetamide-[
24], trichloroacetic- [
26] and dimethoate- [
28] induced oxidative damage in rat liver. Date palm fruits are composed of a fleshy pericarp (flesh) and seeds (pits). The date pits is also high in polyphenolics and antioxidants [
36]. The protective role of date pits extract on oxidative liver damage was also investigated [
35,
37].
Our recent work [
38] presented evidence that the antifibrotic effects of the aqueous extract of date flesh (DFE) and pits (DPE) are not exclusively via antioxidant mechanism but also through downregulation of inflammatory, fibrotic and angiogenic markers. In the present work we aimed to investigate whether the DFE or DPE could exert their antifibrotic effects via ameliorating the oxidative DNA damage and/or stimulating the fibrolytic processes (promotion of ECM degradation) through upregulation of MMPs and downregulation of TIMPs. In addition, our study aimed to explore whether the anti-inflammatory effects exerted by DFE and DPE in fibrotic liver are mediated through alleviation of NF- κB pathway and/or upregulation of HO-1 activity.
Coffee is one of the most popular and highly consumed beverages worldwide. Extensive studies demonstrated the beneficial role of coffee and its components in the protection from various liver diseases [
39‐
42]. Moreover, experimental studies have suggested that the intake of instant coffee, conventional coffee, or any of its components can reduce hepatotoxin-induced liver fibrosis in rats and mice [
43‐
48]. Coffee is a rich source of polyphenols and diterpenes which contribute to the ability of coffee to suppress the genotoxicity [
49‐
51] and NF-κB pathway [
52‐
54] and to enhance HO-1 activity [
55,
56] in different animal models. Therefore and based on its potential and beneficial protective effects on liver, coffee was selected as a reference hepatoprotective agent in the current study.
Methods
Animals
This study was conducted on adult male albino Wistar rats weighing 180–200 g provided by the Experimental Animal Center of King Saud University, College of Pharmacy, Riyadh, KSA and housed at 21–25 °C and a 12 h light/dark cycle in a well-prepared animal house. The animals had free access to pellet food and tap water. The research was conducted in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals and approved by the Animal Care Committee of King Saud University.
Chemicals, kits and antibodies
CCl4, thiobarbituric acid (TBA), trichloroacetic acid (TCA), Bilirubin Assay Kit, normal and low melting agarose and ethidium bromide were purchased from Sigma-Aldrich chemical Co. (St Louis, MO, USA). Date fruits of Mabroom variety were obtained from Kingdom Dates Factory in Riyadh, Kingdom of Saudi Arabia. Date pits powder was purchased from a local company in Riyadh, Kingdom of Saudi Arabia. Instant coffee (Nescafe®,) was obtained from Nestlé (Cheongju, Korea). Commercial kits used for liver enzymes were purchased from Randox Laboratories Ltd. (CRUMLIN, CO. Antrim, UK). ELISA kits for assay of MMP-9, TIMP-1 were obtained from R&D Co. (Quantikine, R&D systems, Minneapolis, MN, USA). ELISA kit for the assay of 8-hydroxy deoxyguanosine (8-OH-dG) was purchased from Abnova Co. (CA, USA). Primary antibodies for detection of α- SMA, COX-2, NF-κB p65, collagen I and TIMP-2 were obtained from Santa Cruz (Santa Cruz Biotechnology, CA, USA). Primary antibodies for immunostaining of HO-1, collagen III and MMP-9 were purchased from Abcam (Cambridge, UK). Secondary antibody was obtained from Sigma-Aldrich. All other reagents were of analytical quality.
Preparation of date flesh extract
The aqueous date extract was prepared according to the method of Al-Qarawi et al. [
35]. The date flesh was manually separated from the pits (seeds). The flesh is then soaked in cold distilled water in a ratio 1:3 (g/ml) and kept for 48 h in a refrigerator (4 °C) with continuous stirring. The extract was then filtered and the aqueous supernatant was used.
The dried pit powder was purchased from a local company in Riyadh. The powder was soaked with water in a ratio 1: 10 (g/ml) under agitation and kept at 4 ° C for 48 h. After 48 h, the extract was filtered and the aqueous supernatant was used [
38]. Aqueous extract was selected for both flesh and pits to get the advantages of all antioxidant contents because most of the antioxidants and active components in dates are extracted in water [
23].
Preparation of CCl4 and induction of liver fibrosis
CCl4 was prepared by dissolving in corn oil (40 % v/v). Liver fibrosis was induced by intraperitoneal injection of 0.4 ml/kg of CCl4 3× weekly for 8 weeks.
Experimental design
Animals were randomly divided into five groups of ten rats each as follows: Group I: Normal control with no treatment; Group II: Model control rats injected with CCl
4 only (0.4 ml /kg; i.p.; 3× weekly for 8 weeks); Groups III and IV: rats injected with CCl
4 3 × weekly for 8 weeks and concomitantly treated with aqueous date flesh extract (DFE; 6 ml/kg) or aqueous date pits extract (DPE; 6 ml/kg); respectively by oral gavage daily for 8 weeks. Group V: is the positive control group composed of rats injected with CCl
4 3× weekly for 8 weeks and concomitantly treated with coffee (300 mg/kg, dissolved in hot water). The dose of both DFE and DPE (6 ml/kg) was selected based on a previous study performed on our lab using 4 doses for each extract (2, 4, 6 and 8 ml/kg) in CCl
4-treated rats [
38]. The end points were Masson trichome staining to detect collagen deposition. The doses 6 and 8 ml/kg showed the best and similar improvement in collagen deposition, so the dose 6 ml/kg was chosen to complete the study [
38]. The dose of coffee was chosen considering four standard cups as the amount drinking daily.
Preparation of serum and tissue homogenate
At the end of 8 weeks, rats were anesthetized and sacrificed by decapitation. Blood samples were collected, and divided into two parts; one part was allowed to coagulate, centrifuged at 3000 rpm for 15 min to separate serum. Sera were used for determination of liver enzymes activities and bilirubin levels. Second part was collected in EDTA-tubes, and centrifuged to separate plasma. Plasma samples were used to determine the levels of advanced oxidation protein products (AOPPs). The livers were removed and cleaned from excess blood with ice-cold normal saline. A part of each liver was fixed with 4 % formalin in phosphate buffered saline (PBS; pH 7.4) for at least 24 h and prepared for immunohistochemical detection of α-SMA, NF-κB p65, COX-2, HO-1, collagen I, collagen III, MMP-9 and TIMP-2. One gram of each liver was sampled and homogenized (20 % w/v) in cold PBS (NaCl 8 g/L, KCl 0.2 g/L, Na2HPO4 144 g/L and KH2PO4 0.24 g/L, pH 7.4) by using Ultra-Turax (IKA-USA) homogenizer. The resulting tissue homogenates were centrifuged at 3000 rpm at 4 °C for ten minutes. The collected supernatant was divided into aliquots and then kept at −80 °C till being used for the assay lipid peroxides, catalase, 8 OH-dG, MMP-9 and TIMP-1.
Evaluation of liver function
Serum activities of liver enzymes, alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and serum levels of total and direct (conjugated) bilirubin were measured with routine laboratory methods using commercially available kits according to manufacturer’s instructions.
Assessment of oxidative stress markers
Determination of thiobarbituric acid reactive substances (TBRS, a marker of lipid peroxidation
Lipid peroxidation was determined by estimating the level of thiobarbituric acid reactive substances (TBARS) measured as malondialdehyde (MDA), according to the method of Ohkawa et al. [
57]. MDA is an end product in the sequence of lipid peroxidation reactions and so was taken as an index for this process. Briefly, the reaction mixture (0.5 ml homogenate + 2.5 ml 20 % TCA +1.0 ml 0.6 % TBA) was heated for 30 min in a boiling water bath. The mixture was then cooled and centrifuged for 10 min at 4 °C. The absorbance of the developed pink-colored product was measured at 535 nm against a reagent blank. 1, 1, 3, 3-tetraethoxypropane, a form of MDA, was used as standard in this assay. The results were expressed as nmol of MDA/g of wet tissue.
Assay of advanced oxidation protein products (AOPPs), a marker of protein oxidation
The determination of plasma AOPPs was based on spectrophotometric detection according to Witko-Sarsat et al. [
58]. Briefly, 200 μl of plasma (diluted 1:5 with PBS as a test), 200 μl of chloramine-T solution (0–100 μmol/L) for calibration and 200 μl of PBS as a blank were applied. A 10 μl of 1.16 M potassium iodide and 20 μl of acetic acid were added, and the absorbance at 340 nm was measured immediately. The concentration of AOPPs was expressed as μmol/l of chloramine-T equivalents.
Assay of catalase (CAT) as enzymatic antioxidant
CAT activity was estimated as the decomposition rate of hydrogen peroxide according to the method of Aebi [
59]. In brief, 50 μl of liver homogenate was diluted with 5 ml of phosphate buffer, and then 2 ml of the diluted homogenate was mixed with 1 ml hydrogen peroxide. The absorbance was read after 15 and 30 s at 240 nm.
Markers of DNA damage
Assay of 8-OHdG
The hepatic levels of 8-OHdG (an abundant form of oxidative DNA damage) were determined by enzyme-linked immunosorbent assay (ELISA) using rat immunoassay kits (Abnova Co). According to the manufacturer’s instructions, two freeze-thaw cycles of liver homogenate samples were performed to break cell membranes, then the homogenates were centrifugated at 5000xg for 5 min and the assay was performed on the supernatant as indicated by the instructions.
Comet DNA assay (marker for DNA fragmentation)
The standard procedure was originally described by Singh et al. [
60] and modified by Hu et al. [
61]. A small piece of liver samples was minced, suspended in 4 ml chilled homogenizing solution (pH 7.5) containing 0.075 M NaCl and 0.024 M Na
2EDTA and then homogenized gently at 500 to 800 rpm in ice. 100 μl of liver homogenate was mixed with 600 μl of low-melting agarose (0.8 % in PBS). 100 μl of this mixture was spread on slides pre-coated with 300 μl of 0.6 % normal melting point agarose (NMP). After application of a third layer of 0.6 % NMP (300 μl), slides were immersed in ice-cold lysis buffer (0.045 M Trisborate- EDTA (TBE) buffer, pH 8.4) for 1 h at 4 °C. Slides were then removed from the lysing solution and placed for 20 min in a horizontal electrophoresis unit filled with an alkaline buffer (1 mM Na
2EDTA and 300 mM NaOH, pH 13) to allow the unwinding of DNA. After the unwinding of DNA, electrophoresis was carried out under standard conditions (25 V, 300 mA, and distance between electrodes 30 cm) for 20 min at room temperature in the same alkaline solution (pH 13). Electrophoresis at high pH results in structures resembling comets, as observed by fluorescence microscopy; the intensity of the comet tail relative to the head reflects the number of DNA breaks. The slides were then neutralized by adding 0.4 M Tris-HCl buffer (pH 7.5), stained with ethidium bromide (20 μg/ml) at 4 °C, covered and stored in sealed boxes at 4 °C until image analysis. All preparation steps were performed under dimmed light to prevent additional DNA damage by UV. Images of 100 randomly selected cells were analyzed for each sample. DNA fragment migration patterns was evaluated with Leitz Orthoplan epifluorescence microscope (magnification 250×) equipped with an excitation filter of 515–560 nm and a barrier filter of 590 nm. The microscope was connected through a camera to a computer-based image analysis system (Comet Assay IV software, Perspective Instruments). Comets were randomly captured at a constant depth of the gel, avoiding the edges of the gel, occasional dead cells, and superimposed comets. DNA damage was measured as tail length (TL = distance of DNA migration from the centre of the body of the nuclear core), tail intensity (TI = % of DNA that migrated from the nuclear core to the tail) and tail moment. The tail moment (TMOM) was determined according to the formula: TMOM = DNA in tail as a % of total DNA x tail length (TL).
ELISA assay of MMP-9 and TIMP-1
The hepatic levels of MMP-9 (a collagen degrading enzyme) and TIMP-1 (a tissue inhibitor of collagen degradation) were determined by enzyme-linked immunosorbent assay using rat immunoassay kits (R&D Systems) according to the manufacturer’s instructions.
Immunohistochemistry for detection of collagen I, collagen III, α-SMA, COX-2, NF-κB p65, HO-1, MMP-9 and TIMP-2
The following primary antibodies were used for immunostaining of paraffin sections of the liver: goat polyclonal anti-collagen I antibody (sc-25,974), mouse monoclonal anti-collagen III antibody (ab 82,354), mouse monoclonal anti-α-SMA (sc-130,617), goat polyclonal anti-COX-2 (sc-1747), mouse monoclonal anti-NF-κB p65 (sc-8008), rabbit polyclonal anti-HO-1 (ab85309), rabbit monoclonal anti-MMP-9 (ab76003) and goat polyclonal anti-TIMP-2 (sc-6835). Immunostaining was performed using Immuno Cruz ABC staining system from Santa Cruz. The procedure involved the following steps: endogenous peroxidase activity was inhibited by 3 % H2O2 in distilled water for 5 min, and then the sections were washed in Tris buffered saline (Sigma, T 5030–100 TAB, pH 7.6) for 10 min. Non-specific binding of antibodies was blocked by incubation with protein block for 5 min. Sections were incubated with the primary antibodies (diluted 1:100, except for anti- α–SMA which is diluted 1:200) for 1 h at room temperature. Sections were washed in Tris buffer for 3 times each for 3 min, and then incubated with biotinylatedantirabbit IgG for 30 min. This was followed by washing in Tris buffer for 3 times, each for 3 min. Peroxidase was detected with working solution of Diaminobenzedine substrate for 10 min. Finally sections were washed in distilled water for 10 min, nuclei were stained with Mayer’s hematoxylin and sections were mounted in DPX. For negative control sections, the same procedure was followed with omission of incubation in the primary antibody.
Statistical analysis
The results are expressed as the mean ± SEM. Statistical comparisons between the groups were performed using one-way analysis of variance (ANOVA) followed by a Tukey-Kramer post hoc test. Statistical analysis was conducted using Prism GraphPad software version 4 (San Diego, California, USA). P values < 0.05 were considered statistically significant.
Discussion
Carbon tetrachloride (CCl
4) intoxication is a frequently used model of liver injury. CCl
4 is activated by hepatic microsomal cytochromes to form the trichloromethyl (CCl3
•) and trichloromethylperoxyl (OOCCl3
•) radicals which are highly unstable and immediately activate oxidation of polyunsaturated fatty acids of hepatocellular membrane leading to its damage and increased permeability [
62]. Another possibility is the covalent binding of CCl3
• to the hepatic microsomal lipids and proteins that damage the integrity of the structure and function of hepatic cell membranes [
62] leading to leakage of liver enzymes into circulation and their elevation in serum (Fig.
1). Liver damage was also confirmed in the present study by the elevated levels of total and conjugated bilirubin that reflect the liver’s inability to take up, process, and secrete bilirubin into the bile. Recently, we reported the hepatoprotective effects of both DFE and DPE in CCl
4-induced fibrosis in rats [
38] via reducing oxidative stress, inactivation of HSCs, and reducing levels of inflammatory and angiogenic markers. In this study we focused on the following mechanisms: i-suppression of genotoxicity, ii- the fibrolytic potential of both extracts via modulating the expression of MMPs and TIMPs, and iii-downregulation of NF-κB pathway and/or upregulation of HO-1.
Cellular lipids are easily attacked by free radicals produced from the metabolism of CCl
4 that initiates a chain reaction to cause lipid peroxidation and cell membrane damage [
62]. Protein is also susceptible to damage by CCl
4-induced free radicals. AOPPs are dityrosine-containing cross-linked protein products formed during oxidative stress and are considered to be reliable markers for estimating the degree of oxidant-mediated protein damage [
63]. In our study, CCl
4 resulted in increased hepatic levels of MDA and plasma levels of AOPPs indicating lipid peroxidation and the oxidative protein damage, respectively. In addition, hepatic CAT activity was reduced reflecting the consumption of this antioxidant enzyme. Moreover, we previously demonstrated that CCl
4 caused depletion of GSH, SOD and GPx confirming the oxidative stress in liver tissue [
38]. Our previous and present work reported that both DFE and DPE exhibited potent protective effects against CCl
4-mediated oxidative damage via decreasing hepatic levels of MDA and increasing the levels and activities of GSH, CAT, SOD and GPx. In addition, the present work also demonstrated that DFE and DPE alleviated protein oxidation as evidenced by reduced plasma levels of AOPPs.
Like other macromolecules such as lipids and proteins, nucleic acids are also attacked by free radicals to cause oxidative DNA damage. DNA strand breaks and formation of 8-OHdG are abundant forms of oxidative damage induced by highly reactive free radicals [
13,
14]. Even when the levels of these radicals are too low to cause such lethal damage, chronic exposure to cells can lead to accumulation of 8-OHdG in DNA. 8-OHdG is generated by oxidation of C8 of guanine and forms pairs with undesirable adenine residue in addition to authentic cytosine residue in DNA, thereby leading to a greatly increased frequency of G:C to T:A transversion mutation and DNA damage [
64]. Moreover, and according to Marnett [
65], the product of lipid peroxidation react with DNA to form adducts MIG, the mutagenic adduct of deoxyguanosine. Alkreathy et al. [
66] demonstrated that CCl
4 degrades the DNA of liver tissue of rats by generating free radicals. In the present study, chronic exposure to CCl
4 lead to a significant rise in the hepatic levels of 8-OHdG in addition to DNA fragmentation indicated by significant increase in tailed DNA %, tail length, tail intensity and tail moments which is probably associated with increased production of reactive oxygen species. Various forms of oxidative damage induced by CCl
4 in liver may be prevented by antioxidants supplementation which represents a rationale for using them in the treatment of liver disorders. In this regard, the protective effects of DFE and DPE against CCl
4-induced genotoxicity were evaluated in the current work. We found that hepatic levels of 8-OHdG and all indices of DNA fragmentation (tailed DNA %, tail length, tail intensity and tail moments) were significantly lower in DFE- and DPE- treated rats supporting the protective effects of both extracts against genotoxicity. These protective effects could be attributed to the antioxidant potential of DFE and DPE that is believed to be due to the wide range of polyphenolic compounds (p-coumaric, ferulic, sinapic acids, flavonoids, anthocyanins, phenolic acids and procyanidins), and trace elements (selenium, copper, zinc and manganese), in addition to vitamin C present in the date palm fruit flesh [
23,
27] and pits [
37]. The antioxidant potential of DFE and DPE may be also related to their ability, particularly DFE, to preserve the expression of the antioxidant enzyme, HO-1, in liver cells (Fig.
10). Our work is the first in vivo study investigating the protective role of dates fruit extract against oxidative DNA damage. Similar to our results, the in vitro study performed by Vayalil [
22] proved the antioxidant and antimutagenic activity of the aqueous date palm fruit extract resulting from the inhibition of both lipid and protein oxidation and also by the aptitude of this extract to scavenge superoxide and hydroxyl radicals. Our results concerning coffee, as a reference antifibrotic agent, supported the previous studies reporting that coffee intake is associated with lower levels of oxidative DNA damage and reduced levels of 8-OHdG [
49‐
51]. Various components of coffee that have been related to such a favorable effect include caffeine, coffee oils kahweol, cafestol and antioxidant substances.
Fibrogenesis is mainly characterized by the activation of HSCs with increased production of ECM particularly collagens and the secretion of α-SMA; the hall mark for HSC activation [
1]. Our results revealed significantly higher expression of collagen I, collagen III and α-SMA in the liver of CCl
4-intoxicated rats indicating fibrogenesis. On the other hand, treatment with DFE and DPE successfully alleviated the fibrotic changes in rat’s liver as indicated by the reduced expression of α-SMA, collagen I and collagen III which confirm our previous results reporting the ability of DFE and DPE to reduce collagen deposition, hydroxyproline and TGF-β1, the most potent fibrotic factor, in hepatic cells [
38]. Among several types of cells and cytokines involved in HSCs activation, the transcription factor NF-κB plays a crucial role [
67]. DNA binding activity of NF-κB is demonstrated in activated but not in quiescent HSCs and activation of HSCs is associated with the nuclear translocation of NF-κB. The current results suggest that the strong immunostaining of NF-κB p65 (Fig.
9, panel B) may play a pivotal role in HSCs activation. Moreover, the current study suggest that the ability of both DFE and DPE to inhibit HSCs activation and collagen accumulation is partly due to blocking NF-κB activation indicated in the present study by decreased NF-κB p65 immunoreactivity (Fig.
9, panels C and D). We previously presented additional mechanism of the inhibitory effect of DFE and DPE on HSCs activation via reducing the levels of TGF-β1, TNF-α, IL-6 and IL-1β, the most important cytokines involved in HSCs activation [
38].
To further investigate the antifibrotic mechanisms of DFE and DPE in hepatic cells, their ability to induce collagen degradation was elucidated in the current study. In healthy liver, MMPs and TIMPs play an important role in inducing and preventing the degradation of the ECM, respectively. The imbalance between MMPs and TIMPs is considered a pivotal mechanism of ECM deposition and liver fibrogenesis [
5]. Among different MMPs and TIMPs, MMP-9 is known as the regulator for the breakdown of ECM, while TIMP-1 and -2 exhibit anti-fibrolytic and growth-stimulated activities [
68]. In this study, CCl
4-intoxicated rats revealed significantly higher levels and expression of MMP-9 which is consistent with the previous studies conducted on chronic models of CCl
4-induced liver fibrosis [
69‐
71]. Moreover, MMP-9 is produced in CCl
4-induced liver injury after a single injection [
72] and in hepatitis C virus-induced cirrhosis [
73]; however, its activity was not related to the degree of fibrosis [
74]. In this regard, the levels and expression of MMP-9 in our study were increased in CCl
4-intoxicated rats’ liver, possibly due to HSC activation [
3]. It has been demonstrated that the antifibrotic efficacy is associated with a decreased hepatic level of MMP-9 [
70]. However, in our study, no significant change in the levels and expression of MMP-9 was observed by treatment with DFE, DPE or coffee compared to CCl
4-intoxicated rats suggesting the antifibrotic effect may not be related to modulation of MMP-9 activity.
TIMP-1 and TIMP-2 are capable of inhibiting the activities of all known MMPs and, in consistent with our results, their expressions are increased in CCl
4-induced liver fibrosis [
69,
70,
74]. Activation of HSCs in culture and in vivo is accompanied by increased expression and secretion of TIMP-1 and TIMP-2 [
74,
75]. Therefore in the presence of a hepatotoxic agent, HSCs are activated, and the TIMP-1 and -2 are upregulated, leading to fibrogenesis. On the other hand, fibrosis resolution has been correlated with a diminution of TIMP-1 and TIMP-2 [
75,
76], therefore, TIMP-1 and TIMP-2 represent important therapeutic target of the antifibrotic strategies for chronic liver disease [
69,
76]. Our results revealed significant reduction in the hepatic levels of TIMP-1 and expression of TIMP-2 in rats treated with DFE or DPE which imply a new and significant antifibrotic mechanism for DFE or DPE via fibrolytic activity. This significant downregulation in the hepatic level of TIMP-1 and TIMP-2 by DFE and DPE might be due to the following: First, the inhibition of HSCs activity, as indicated by lowered expression of α-SMA (Fig.
5, panel C and D); second, the diminished hepatic levels of TGF-β1 by DFE and DPE [
38]. This inhibitory effect on TGF-β1 is important because TGF-β1 plays a key role in modulating the levels of ECM via inhibiting MMPs, while simultaneously up-regulates expression of TIMPs [
77] leading to failure of ECM degradation and accumulation of collagen in hepatic tissue. The third explanation of the fibrolytic activity of DFE and DPE is their inhibitory effect on the secretion of inflammatory cytokines, TNF-α, IL-6 and IL-1β [
38] which are known to upregulate the TIMP-1 levels in rat and human hepatocytes [
78]. Our suggestion is supported by the study of Roderfeld et al. [
72] who demonstrated that cytokine blockade inhibits the expression of TIMP-1 and up-regulates the expression of MMP-9. In the current study, immunohistochemical examinations showed that livers from DFE- and DPE-treated rats exhibited significant reduction in collagens type I and type III reactivity (Fig.
4) suggesting the beneficial role of DFE and DPE in the removal of deposited collagen. This enhanced collagenolytic activity could be strongly associated to the decreased TIMP-1 and TIMP-2 levels by both extracts. In conclusion, enhancement of matrix degradation might be involved in the antifibrotic effects of DFE and DPE.
The proinflammatory mediators, TNF-α, IL-6 and IL-1β can promote fibrosis via different mechanisms. Recently, we reported the anti-inflammatory effects of DFE and DPE in CCl
4-iduced liver fibrosis via reducing the aforementioned mediators [
38]. However, the data concerning anti-inflammatory effect of dates in liver toxicity is still poor and inadequate. In the current study, we aimed to investigate whether the anti-inflammatory effects of DFE and DPE are mediated through the modulation of NF-κB and/or HO-1 pathways.
NF-κB provides an important mechanism of the inflammatory response in liver fibrosis. Activation of NF-κB leads to production of the proinflammatory cytokines, followed by activation of other inflammatory mediators, such as COX-2 and iNOS [
9]. In the current study, CCl
4-injured liver demonstrated strong immunostaining of NF-κB p65 subunit that is located in nucleus. Cytoplasmic NF-κB activation and its subsequent nuclear translocation in CCl
4-injured livers are suggested to be induced by CCl
4-generated free radicals [
79]. NF-κB was also activated during transdifferentiation of HSCs into myofibroblasts like cells [
1]. Importantly, the accumulation and nuclear translocation of the NF-κB p65 subunit in the liver cells of CCl
4-intoxicated rats was significantly attenuated by treatment with DFE or DPE suggesting their anti-inflammatory activity through suppression of NF-κB activation. The inhibitory effects of DFE and DPE on NF-κB p65 may be attributed to their role in HSCs inactivation or may be related to their polyphenols, flavonoids and anthocyanins contents which are documented to suppress COX-2 expression and inhibit NF-κB translocation in previous studies [
80]. Moreover, the inhibitory effect of DFE and DPE on NF-κB could be further explained by their ability, particularly DFE, to preserve HO-1 enzymatic activity as demonstrated in the current study in Fig.
10 (panels C and D). Yang et al. [
81] demonstrated a potential mechanism that HO-1 prevents the expression of NF-κB in fibrotic liver tissue. In addition, Xue et al. [
18] suggest that high levels of HO-1 expression may decrease NF-κB expression to lessen the inflammatory reaction at 6 h after reperfusion in cirrhotic rats. Concerning coffee, our results supports previous data reported the inhibitory effect of coffee on NF-κB in vitro and in vivo [
52‐
54]. The coffee-induced NF-κB inhibition activity was attributed mainly to polyphenolics and melanoidins, two major coffee chemical groups [
53,
54]. The upregulation of HO-1 enzyme activity as demonstrated in the current study (Fig.
10, panel E) may further explain the role of coffee in inhibiting NF-κB activation.
The cyclooxygenase (COX) pathway is responsible for the conversion of arachidonic acid into prostaglandins; the most widely recognized mediators of inflammation. COX-1 and COX-2 are two isoforms of the COX enzyme. Accumulated evidences indicate that the COX-2 pathway has been implicated in liver inflammation, matrix remodelling, fibrosis progress and development of hepatocellular carcinoma [
82,
83]. Previous data also documented increased expression and enhanced formation of COX-2 in CCl
4-induced liver injury [
82‐
84] which is consistent with our results where strong immunoreactivity of COX-2 was detected in liver of CCl
4-treated rats. NF-κB is involved in the regulation of COX-2 gene expression by binding to its promoter regions and enhancing the COX-2 transcription [
85]. The enhanced activation and translocation of NF-κB p65 in the present study may explain the increased expression of COX-2 in CCl
4-induced liver injury. Importantly, COX-2 inhibition was beneficial in CCl
4-induced fibrosis as it reduces cell growth and triggers apoptosis in HSCs and exerts antifibrogenic actions [
82‐
84]. It is obvious from our study that both DFE and DPE down-regulated the activation of NF-κB and simultaneously suppressed COX-2 expression, suggesting the inhibition of this proinflammatory pathway may be a potential strategy for prevention of inflammatory liver injury and fibrogenesis. In agreement with our results, Zhang et al. [
86] reported that Ajwa, a variety of date palm
Phoenix dactylifera L. is very active as anti-inflammatory and inhibited both COX-1, COX-2 activity.
The HO-1 plays an important role in various pathophysiological conditions owing to its antioxidative, anti-inflammatory, antiapoptosis, and potent cytoprotective properties [
16‐
20]. Thus, pharmacological modulation of the HO-1 system may represent an effective and cooperative strategy to mitigate liver injury. In the current study, CCl
4 induced downregulation of HO-1 expression (Fig.
10, Panel B) which may contribute to oxidative stress, inflammatory response and fibrogenesis in hepatic cells. Co-administration of DFE, DPE or coffee significantly ameliorated this reduction, particularly with DFE and coffee suggesting a new mechanism for their antifibrotic action. Previous reports demonstrated that HO-1 induction by coffee is attributed to polyphenolic constituents, the most abundant form being chlorogenic acid and caffeic acid. In addition, it has been demonstrated that caffeic acid and kahweol, polyphenolic and diterpine constituents of coffee, drastically activated the HO-1 gene with elevated induction of HO-1 leading to the control of intracellular levels of ROS [
55,
56]. Except for the current study, no data are available concerning the role of DFE or DPE on the induction HO-1. Future studies are recommended to evaluate which constituents of dates are involved in the HO-1 induction in hepatic cells.